Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
"I am so tired of spending money elsewhere. I am tired of the industrial war complex getting all of our hard-earned tax dollars," said one Republican. by Callum Sutherland by Bill Ready Commission of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results